Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Status:
Terminated
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
Evaluate the safety and efficacy of lucinactant administered by bronchoalveolar lavage (BAL)
in the treatment of meconium aspiration syndrome (MAS) in newborn infants.